#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Muscular dystrophy Arterial disorder Aplastic anaemia Dementia with Lewy bodies Thrombotic microangiopathy Urea cycle disorder Synovial sarcoma recurrent Cortical dysplasia IPEX syndrome Epstein-Barr virus infection Endometrial cancer recurrent Dementia Breast cancer Systemic scleroderma Synovial sarcoma More trials…

    Learn about Rare Diseases

    Angiosarcoma non-metastatic Kearns-Sayre syndrome – Life with Disease Fragile X syndrome – Basic Information Cystic fibrosis lung – Trials in Disease Malignant fibrous histiocytoma – Diagnostics Myelodysplastic syndrome with excess blasts – Trials in Disease Marginal zone lymphoma refractory – Trials in Disease Extranodal marginal zone B-cell lymphoma (MALT type) Synovial sarcoma recurrent – Basic Information Breast angiosarcoma – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Lanreotide Db-1303 Ttx-030 Ciclesonide Aminocaproic Acid Disulfiram HYDROXYCHLOROQUINE Sorafenib Tosilate Brimonidine Tartrate Prednisolone L-METHIONINE Trazodone Cdr132L Sodium Almagate Bortezomib Cefepime Hydrochloride Trifluridine Dactylis Glomerata Dexlansoprazole Darolutamide More therapies…

    Learn about Your Condition

    Diabetic foot Immune-mediated myositis Carcinoid syndrome Vulvovaginal candidiasis Hyperparathyroidism secondary Dystonia Oesophageal food impaction Round cell liposarcoma Papilloma viral infection Eosinophilic gastritis Endocarditis Colon cancer stage II Metastases to lymph nodes Cervix carcinoma Gastric cancer stage IV More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Otorhinolaryngologic Diseases

  • Study on Lebrikizumab for Adults with Chronic Rhinosinusitis and Nasal Polyps Using Intranasal Corticosteroids

    Recruiting

    3 1 1
    Investigated Diseases:
    • Chronic rhinosinusitis with nasal polyps
    Investigated Drugs:
    • Lebrikizumab
    • Mometasone Furoate
    Belgium Bulgaria Denmark Finland Germany Hungary +5

  • Study on Dupilumab for Patients with Chronic Rhinosinusitis with Nasal Polyps and Eosinophilic Otitis Media

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Otitis media
    • Chronic rhinosinusitis with nasal polyps
    Investigated Drugs:
    • Dupilumab
    The Netherlands

  • Study on Mepolizumab and Surgery for Patients with Chronic Rhinosinusitis with Nasal Polyps

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Chronic rhinosinusitis with nasal polyps
    Investigated Drugs:
    • Mepolizumab
    Denmark

  • Study on the Effectiveness of Autologous Adipose-Derived Stromal Vascular Fraction Cells for Patients with Scarred Vocal Folds

    Recruiting

    2 1
    Investigated Drugs:
    • Autologous Adipose Tissue-Derived Stromal Vascular Fraction Cells
    • Human Serum Albumin 5%
    • Sodium Chloride
    France

  • Imaging Study with 89Zr-Bevacizumab for Predicting Treatment Effects in Patients with NF2-Related Schwannomatosis

    Recruiting

    2 1 1
    Investigated Diseases:
    • Neurofibromatosis
    Investigated Drugs:
    • Bevacizumab Zirconium Zr-89
    The Netherlands

  • Study of Chemoradiation with Carboplatin and Paclitaxel for Elderly Patients with Esophageal Cancer

    Recruiting

    1 1 1 1
    Investigated Diseases:
    • Oesophageal carcinoma
    Investigated Drugs:
    • Carboplatin
    • Paclitaxel
    France
Previous Page
1 2 3 4 5 … 11
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!